Biotech Values

[biomaven0]

A survey of 146 institutional investors

I'm not sure I buy a "wisdom of the crowds" thesis in trials like these. I don't think anyone not possessing inside information has the faintest idea of how these trials will come out, and those that do think they have an idea are likely deluding themselves.

Peter